ELIEZER HERNANDEZ: Open Payments
NPI 1679247159 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 45 payments from 17 companies in 2025. Trend: 2023 $1,813 · 2024 $1,684 · 2025 $1,033
Food & beverage: $1,033
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $227 |
| ABBVIE INC. | 9 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $111 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| Viatris Specialty LLC | 3 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $66 |
| Indivior Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $41 |
| Lilly USA, LLC | 2 | $41 |
| Lundbeck LLC | 2 | $40 |
Products named: REXULTI, VRAYLAR, CAPLYTA, YUPELRI, Kerendia, AIRSUPRA, FARXIGA, SUBLOCADE.
Industry payments across NY — which companies pay providers there.
